LLY compared with MENS: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

MENSJyong Biotech Ltd.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

MENSJyong Biotech Ltd.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

Q1 FY26±5.3%▲+9.80%×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

MENS

No earnings history for MENS.

= impliedLLY realized, solidMENS realized, hatchedOne scale, both sides: full bar = 11%× = |realized| ÷ impliedSource: market data

LLYELI Lilly & Co

1,360.90· pre 1,383.86· delayed

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

MENSJyong Biotech Ltd.

1.77· pre 1.82· delayed

Pre-marketNov 9 '26delayed

Mkt cap$131.4MRevenue—Revenue—

Compare

Pre-marketNov 9 '26delayed

LLYELI Lilly & Co

MENSJyong Biotech Ltd.

1,360.90pre 1,383.86delayed

Price

1.77pre 1.82delayed

$1.2T

Mkt cap

$131.4M

Q3 FY26$24.4B

Revenue

—

FY25$65.2B

Revenue

—

LLY1,360.90vsMENS1.77Pre-marketNov 9 '26delayed